Back to results
US 2020/0368222 A1Published application
Methods of treating radiation induced gastrointestinal syndrome (rigs) and related disease states using yel002/bcn057
AssigneesUniversity of Kansas, BCN Biosciences L.L.C.
InventorsSubhrajit Saha, Andrew J. Norris
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to method of treatment for treating or ameliorating various conditions caused by radiation exposure such as RIGS, enteritis, oral mucositis, mucositis, and proctitis by the administration of a compound Yel002/BCN057 or an analog thereof.
Claims7
A method of treating radiation induced damage to epithelial cells in a subject in need thereof, the method comprising the step of administering to the subject a therapeutically effective amount of a compound of Formula I:
- wherein R1 and R2 are independently selected from the group consisting of hydrogen, amino, amide, F, Cl, Br, I, nitro, alkoxy, hydroxyl, thiol, alkylthio, acyl carboxylic acid, ester, sulfonyl, sulfonamide, —SO4H, optionally substituted C1-C20 alkyl, optionally substituted C1-C20 alkenyl, optionally substituted C1-C20 alkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted heterocycloalkyl, optionally substituted heteroaryl, and optionally substituted phenyl;
- and
- wherein R3 is optionally substituted C1-C20 alkyl, optionally substituted C1-C20 alkenyl, optionally substituted C1-C20 alkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted heterocycloalkyl, optionally substituted heteroaryl, or optionally substituted phenyl.
Dependencies are inferred from the claim text.